Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 18.82% is 108% above its 5-year average of 9.06%, near the high end of its 5-year range (-26.31%–28.18%).
870.76% above its 12-month average of 1.94%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -26.31%.
EBITDA MARGIN
18.82%
EBITDA MARGIN AVG TTM
1.94%
EBITDA MARGIN AVG 3Y
16.75%
EBITDA MARGIN AVG 5Y
9.06%
EBITDA MARGIN AVG 10Y
3.05%
EBITDA MARGIN AVG 15Y
3.56%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+870.76%
CURRENT VS 3Y AVG
+12.33%
CURRENT VS 5Y AVG
+107.64%
CURRENT VS 10Y AVG
+516.60%
CURRENT VS 15Y AVG
+429.00%
CURRENT VS 20Y AVG
N/A
MiMedx Group, Inc.
Market Cap
$658.11M
EBITDA Margin
18.82%
TTM Avg
1.94%
3Y Avg
16.75%
5Y Avg
9.06%
Market Cap
$661.68M
EBITDA Margin
-30265.74%
TTM Avg
-30265.74%
3Y Avg
-29547.55%
5Y Avg
-23057.25%
Market Cap
$657.39M
EBITDA Margin
-5.80%
TTM Avg
-5.80%
3Y Avg
-5.80%
5Y Avg
-5.80%
Market Cap
$661.38M
EBITDA Margin
-178.29%
TTM Avg
-244867.52%
3Y Avg
-123424.79%
5Y Avg
-82415.31%
Market Cap
$655.68M
EBITDA Margin
-4381.82%
TTM Avg
-5481.88%
3Y Avg
-5481.88%
5Y Avg
-3660.27%
Market Cap
$680.78M
EBITDA Margin
-1285.45%
TTM Avg
-897.10%
3Y Avg
-897.10%
5Y Avg
-897.10%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $658.11M | 18.82% | 1.94% | 16.75% | 9.06% |
| Helus Pharma Inc. (HELP)vs › | $661.68M | -30265.74% | -30265.74% | -29547.55% | -23057.25% |
| Starling Oncology, Inc. (STLN)vs › | $657.39M | -5.80% | -5.80% | -5.80% | -5.80% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $661.38M | -178.29% | -244867.52% | -123424.79% | -82415.31% |
| Prime Medicine, Inc. (PRME)vs › | $655.68M | -4381.82% | -5481.88% | -5481.88% | -3660.27% |
| Annexon, Inc. (ANNX)vs › | $667.66M | N/A | N/A | N/A | N/A |
| Solid Biosciences Inc. (SLDB)vs › | $680.78M | -1285.45% | -897.10% | -897.10% | -897.10% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $680.46M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $632.51M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $692.43M | -4821.38% | -3832.53% | -2582.73% | -1806.92% |
Gross Margin
78.8%
EBITDA Margin
18.8%
Operating Margin
15.3%
Net Margin
1.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -26.31% |
| 2026-03-31 | -24.46% |
| 2025-12-31 | 20.57% |
| 2025-09-30 | 24.16% |
| 2025-06-30 | 15.73% |
| 2025-03-31 | 13.01% |
| 2024-12-31 | 15.12% |
| 2024-09-30 | 14.65% |
| 2024-06-30 | 28.18% |
| 2024-03-31 | 16.49% |
| 2023-12-31 | 18.76% |
| 2023-09-30 | 14.65% |
| 2023-06-30 | 14.39% |
| 2023-03-31 | 0.82% |
| 2022-12-31 | 3.19% |
| 2022-09-30 | -8.97% |
| 2022-06-30 | -12.80% |
| 2022-03-31 | -14.04% |
| 2021-12-31 | 6.51% |
| 2021-09-30 | 0.10% |
| 2021-06-30 | 1.68% |
| 2021-03-31 | -9.09% |
| 2020-12-31 | -21.22% |
| 2020-09-30 | -12.23% |
| 2020-06-30 | -7.76% |
| 2020-03-31 | -19.38% |
| 2019-12-31 | -3.98% |
| 2019-09-30 | 18.13% |
| 2019-06-30 | -22.48% |
| 2019-03-31 | -17.26% |
| 2018-12-31 | -7.26% |
| 2018-09-30 | 2.36% |
| 2018-06-30 | 3.37% |
| 2018-03-31 | 5.28% |
| 2017-12-31 | 28.81% |
| 2017-09-30 | 12.15% |
| 2017-06-30 | 11.56% |
| 2017-03-31 | 10.55% |
| 2016-12-31 | 14.16% |
| 2016-09-30 | 9.58% |
| 2016-06-30 | 8.42% |
| 2016-03-31 | 5.64% |
| 2015-12-31 | 16.47% |
| 2015-09-30 | 15.14% |
| 2015-06-30 | 13.81% |
| 2015-03-31 | 11.86% |
| 2014-12-31 | 13.19% |
| 2014-09-30 | 12.76% |
| 2014-06-30 | 0.50% |
| 2014-03-31 | -2.03% |
| 2013-12-31 | -5.19% |
| 2013-09-30 | 1.17% |
| 2013-06-30 | -2.50% |
| 2013-03-31 | 1.16% |
| 2012-12-31 | -3.34% |
| 2012-09-30 | 0.71% |
| 2012-06-30 | 6.91% |
| 2012-03-31 | -5.05% |
| 2011-12-31 | -75.37% |
| 2011-09-30 | -56.66% |
| 2011-06-30 | -101.94% |
| 2011-03-31 | -268.92% |
| 2010-12-31 | -885.04% |
| 2010-09-30 | -2381.39% |
| 2010-06-30 | -750.93% |
| 2010-03-31 | -1976.68% |
| 2008-06-30 | -1848.78% |
